[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100607161":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":25,"responsibleParty":38,"collaborators":10,"id":40,"slug":41,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":44,"acronym":10,"eligibilityCriteria":45,"healthyVolunteers":42,"sex":46,"minAge":47,"maxAge":48,"enrollmentInfo":49,"targetDuration":10,"studyType":52,"phases":10,"briefSummary":53,"conditions":54,"keywords":10,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":65},{"fullName":5,"class":6},"NYU Langone Health","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Men with Prostate Cancer",null,"Men who receive cryotherapy for ablation of clinically localized prostate cancer.",[13],{"name":14,"affiliation":5,"role":15},"James Wysock, MD","PRINCIPAL_INVESTIGATOR",[17,22],{"name":18,"role":19,"phone":20,"phoneExt":10,"email":21},"Majlinda Tafa","CONTACT","(646) 825-6338","Majlinda.Tafa@nyulangone.org",{"name":14,"role":19,"phone":23,"phoneExt":10,"email":24},"(646) 825-6366","James.Wysock@nyulangone.org",[26],{"facility":5,"status":27,"city":28,"state":28,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":10},"RECRUITING","New York","10016","United States","US",{"type":33,"coordinates":34},"Point",[35,36],-74.00597,40.71427,{"lat":36,"lon":35},{"type":39,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100607161","prospective-database-of-clinical-outcomes-following-cryotherapy-for-ablation-of-clinically-localized-prostate-cancer-100607161",false,"NCT07184957","Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer","Inclusion Criteria:\n\n* Evidence of focal prostate cancer confined to the prostate based on MRI imaging and prostate biopsy\n* Patients with clinically localized prostate cancer (no evidence for or concern for metastatic spread of cancer outside of the prostate) will be counseled regarding treatment options. Those selecting focal Cryo prostate ablation will then be offered inclusion into this data collection.\n\nExclusion Criteria:\n\n* Men that are not diagnosed with prostate cancer.\n* Men that are diagnosed with clinically localized prostate cancer, but select other treatment options as their desired treatment.","MALE","40 Years","85 Years",{"count":50,"type":51},1000,"ESTIMATED","OBSERVATIONAL","This will be a prospectively maintained research database. The purpose is to record baseline parameters and treatment outcomes following of Cryotherapy for ablation of clinically localized prostate cancer.",[55],"Prostate Cancer","2026-08-05",{"date":58,"type":59},"2026-08-07","ACTUAL",{"date":61,"type":59},"2017-05-01",{"date":63,"type":51},"2040-12-31",{"name":5,"class":6},1]